Published in HPB (Oxford) on August 06, 2014
Recipient Age and Mortality Risk after Liver Transplantation: A Population-Based Cohort Study. PLoS One (2016) 0.75
The impact of morbid obesity on resource utilization after renal transplantation. Surgery (2016) 0.75
Hospital Utilization of Nationally Shared Liver Allografts from 2007 to 2012. World J Surg (2016) 0.75
Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival. Liver Transpl (2007) 2.59
Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg (2007) 2.23
Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Liver Transpl (2012) 2.12
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl (2011) 1.79
Liver and intestine transplantation in the United States 1998-2007. Am J Transplant (2009) 1.73
Outcome of liver transplantation in septuagenarians: a single-center experience. Arch Surg (2007) 1.69
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Kidney transplantation in the elderly. Semin Nephrol (2009) 1.27
The elderly liver transplant recipient: a call for caution. Ann Surg (2001) 1.15
Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl (2010) 1.08
Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc (2009) 1.07
Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int (2001) 1.05
The economic implications of broader sharing of liver allografts. Am J Transplant (2011) 0.98
Age is an important predictor of kidney transplantation outcome. Nephrol Dial Transplant (2011) 0.90
Alemtuzumab induction in renal transplantation. N Engl J Med (2011) 4.13
Factors influencing readmission after pancreaticoduodenectomy: a multi-institutional study of 1302 patients. Ann Surg (2012) 2.93
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A (2008) 2.51
Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study. J Gastrointest Surg (2014) 2.15
Donors with central nervous system malignancies: are they truly safe? Transplantation (2003) 2.12
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
Malignancy after transplantation. Transplantation (2005) 1.92
Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology (2009) 1.73
Surgical management of acute cholecystitis at a tertiary care center in the modern era. Arch Surg (2010) 1.70
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation (2008) 1.66
Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012. Liver Transpl (2014) 1.63
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58
Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg (2011) 1.57
Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg (2013) 1.56
Colectomy performance improvement within NSQIP 2005-2008. J Surg Res (2011) 1.50
Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res (2010) 1.49
Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc (2009) 1.48
Hand-assisted laparoscopic living-donor nephrectomy as an alternative to traditional laparoscopic living-donor nephrectomy. Am J Transplant (2002) 1.44
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation (2002) 1.43
Patient-ventilator asynchrony in a traumatically injured population. Respir Care (2013) 1.42
Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration. J Cell Biochem (2008) 1.41
Temporary silastic mesh closure for adult liver transplantation: a safe alternative for the difficult abdomen. Liver Transpl (2007) 1.40
Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg (2005) 1.39
Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg (2009) 1.34
An initial experience and evolution of laparoscopic hepatic resectional surgery. Surgery (2004) 1.26
De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation (2009) 1.25
Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection. Transplantation (2010) 1.25
Interferon regulatory factor 6 promotes cell cycle arrest and is regulated by the proteasome in a cell cycle-dependent manner. Mol Cell Biol (2008) 1.22
Predictors of conversion to thoracotomy for video-assisted thoracoscopic lobectomy: a retrospective analysis and the influence of computed tomography-based calcification assessment. J Thorac Cardiovasc Surg (2012) 1.22
National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg (2009) 1.22
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology (2012) 1.21
Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle (2008) 1.20
West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation (2004) 1.18
Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg (2008) 1.16
Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastrointest Surg (2008) 1.11
Surgeon volume metrics in laparoscopic cholecystectomy. Dig Dis Sci (2009) 1.11
Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int (2012) 1.10
Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol (2009) 1.10
Trends in surgical management for acute cholecystitis. Surgery (2008) 1.09
A necessary role for GluR1 serine 831 phosphorylation in appetitive incentive learning. Behav Brain Res (2008) 1.09
Predictors of major complications after laparoscopic cholecystectomy: surgeon, hospital, or patient? J Am Coll Surg (2010) 1.07
Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant (2005) 1.07
Does increasing insurance improve outcomes for US cancer patients? J Surg Res (2013) 1.05
All massive transfusion criteria are not created equal: defining the predictive value of individual transfusion triggers to better determine who benefits from blood. J Trauma (2011) 1.04
Surgery and radiotherapy for retroperitoneal and abdominal sarcoma: both necessary and sufficient. Arch Surg (2010) 1.03
Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis (2008) 1.03
Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in kidney and kidney-pancreas transplant recipients. Transplantation (2002) 1.03
A comparison of tacrolimus and cyclosporine in liver transplantation: effects on renal function and cardiovascular risk status. Am J Transplant (2005) 1.02
Adenocarcinoma of the rectum in patients under age 40 is increasing: impact of signet-ring cell histology. Dis Colon Rectum (2015) 1.02
IFN-gamma regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells. J Cell Biochem (2008) 1.02
Utilization of laparoscopic and open inguinal hernia repair: a population-based analysis. J Laparoendosc Adv Surg Tech A (2009) 1.01
Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg (2010) 1.01
Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: comparison of early steroid withdrawal and chronic steroids. Clin Transplant (2008) 1.01
EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther (2009) 1.00
Proteasome inhibition for antibody-mediated rejection. Curr Opin Organ Transplant (2009) 1.00
Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition. Transplantation (2011) 0.98
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg (2013) 0.98
Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford) (2011) 0.98
Narp regulates long-term aversive effects of morphine withdrawal. Behav Neurosci (2008) 0.98
Malignant melanoma in solid transplant recipients: collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis. Arch Dermatol (2011) 0.97
Donor postextubation hypotension and age correlate with outcome after donation after cardiac death transplantation. Transplantation (2008) 0.97
High volume and outcome after liver resection: surgeon or center? J Gastrointest Surg (2008) 0.97
Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study. J Gastrointest Surg (2011) 0.96
The American Society of Colon and Rectal Surgeons' Clinical Practice Guideline for the Evaluation and Management of Constipation. Dis Colon Rectum (2016) 0.96
A role for alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid GluR1 phosphorylation in the modulatory effects of appetitive reward cues on goal-directed behavior. Eur J Neurosci (2008) 0.96
Laparoscopic liver resection. J Am Coll Surg (2005) 0.95
The faltering solid organ donor pool in the United States (2001-2010). World J Surg (2012) 0.95
Targeting the ubiquitin+proteasome system in solid tumors. Semin Hematol (2012) 0.95
Association between donor-specific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation (2011) 0.95
Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation (2004) 0.94
Considerations for diagnosis and management of ileostomy-related malignancy: a report of two cases. Ostomy Wound Manage (2014) 0.94
Total pancreatectomy: a national study. HPB (Oxford) (2009) 0.93
Increasing age is a predictor of short-term outcomes in esophagectomy: a propensity score adjusted analysis. J Gastrointest Surg (2014) 0.93
Current status of surgical management of acute cholecystitis in the United States. World J Surg (2008) 0.93
Has the 80-hour workweek improved surgical resident education in New England? J Surg Educ (2009) 0.92
Characteristics and survival patterns of solid organ transplant patients developing de novo colon and rectal cancer. Dis Colon Rectum (2004) 0.92
Rapid reduction in donor-specific anti-human leukocyte antigen antibodies and reversal of antibody-mediated rejection with bortezomib in pediatric heart transplant patients. Transplantation (2012) 0.92
Is the growth in laparoscopic surgery reproducible with more complex procedures? Surgery (2009) 0.92
In-hospital mortality for liver resection for metastases: a simple risk score. J Surg Res (2009) 0.91
Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg (2010) 0.90
Basic and clinical research in polyomavirus nephropathy. Exp Clin Transplant (2004) 0.90
Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg (2008) 0.90
In-hospital mortality from liver resection for hepatocellular carcinoma: a simple risk score. Cancer (2010) 0.90
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant (2005) 0.90
BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol (2008) 0.90
Desensitization in kidney transplantation: review and future perspectives. Clin Transplant (2014) 0.90
Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. Virology (2010) 0.89
Risk factors and consequences of anastomotic leak after colectomy: a national analysis. Dis Colon Rectum (2015) 0.89
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study. Clin Transplant (2010) 0.88